| ²é¿´: 476 | »Ø¸´: 3 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
¡¾×ÊÔ´¡¿Ó¢ÎÄÎÄÏ×3ƪ
|
||
|
001 Sorafenib: a review of its use in advanced hepatocellular carcinoma. 002 Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials. 003 Hilger RA, Richly H, Grubert M, Kredtke S, Thyssen D, Eberhardt W, Hense J, Schuler M, Scheulen ME. |
» ²ÂÄãϲ»¶
25ÄêʳƷרҵ¿¼²© Ï£Íû²©µ¼¿´¿´
ÒѾÓÐ1È˻ظ´
¸Ð¹ÙÆÀ¶¨ÈÃÌṩÈËÀàÑо¿Â×ÀíίԱ»á¶Ô´ËÏ×÷µÄÅú×¼ÐÒé±àºÅ
ÒѾÓÐ13È˻ظ´
ҽѧ²¡Ô΢ÉúÎïÓë¸ÐȾÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ262È˻ظ´
25ÄêʳƷרҵ¿¼²© Ï£ÍûÀÏʦÊÕÁô
ÒѾÓÐ0È˻ظ´
·Ç°Ñ´úл×éѧÇó½Ì
ÒѾÓÐ1È˻ظ´
Ë«Ëõëå·´Ó¦×Éѯ
ÒѾÓÐ1È˻ظ´
Çóµ÷¼Á ½ÓÊÜ¿çרҵ
ÒѾÓÐ0È˻ظ´
105300³õÊÔ320Çóµ÷¼Á£¡
ÒѾÓÐ0È˻ظ´
1053¹«¹²ÎÀÉú³õÊÔ320Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
3Â¥2010-01-27 13:03:49
2Â¥2010-01-27 13:02:23
4Â¥2010-01-27 17:25:51














»Ø¸´´ËÂ¥